SCR 8: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Sponsors

Sponsors by party (alphabetical): Republican 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. April 14, 2025Reported from HLT (Stand. Com. Rep. No. 2071), recommending referral to FIN.
2. April 14, 2025Report adopted; referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and none excused (0).
3. April 11, 2025The committee on HLT recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 7 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Alcos; Ayes with reservations: none; Noes: none; and 2 Excused: Representative(s) Takenouchi, Garcia.
4. April 8, 2025Resolution scheduled to be heard by HLT on Friday, 04-11-25 10:00AM in conference room 329 VIA VIDEOCONFERENCE.
5. April 4, 2025Referred to HLT, FIN, referral sheet 28
6. March 31, 2025Resolution Adopted as amended (SD1). Aye(s) with reservations: Senator(s) McKelvey. Noes, 0 (none). Transmitted to House.
7. March 31, 2025Received from Senate (Sen. Com. No. 415) in amended form (SD 1).
8. March 28, 2025Waived referral to WAM.
9. March 28, 2025One Day Notice 03-31-25
10. March 24, 2025The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.
11. March 24, 2025Reported from HHS (Stand. Com. Rep. No. 1360), as amended (SD 1), with recommendation of referral to WAM.
12. March 24, 2025Report adopted, as amended (SD 1) and referred to WAM.

Showing 12 most recent of 15 actions. Full history